MERCK U.S. PATENT RIGHTS
FOR PRODUCTS

In accordance with Section 287(a) of Title 35 of the United States Code, the following list identifies Merck’s rights in U.S. patents associated with the relevant product. This list may be a subset of Merck’s rights in U.S. patents directed to the relevant product.



A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | X | Y | Z



Activyl®
(indoxacarb)
U.S. Patent No. 8,475,818
BRAVECTO®
(fluralaner)
U.S. Patent No. 7,662,972
U.S. Patent No. 8,796,464
U.S. Patent No. 8,022,089
U.S. Patent No. 8,492,311
U.S. Patent No. 9,173,870
FORTEGRA®
Live eimeria vaccine
U.S. Patent No. 9,050.281
Nobivac®: Canine Flu Bivalent
Canine influenza virus
U.S. Patent No. 7,959,929
U.S. Patent No. 9,345,758
U.S. Patent No. 8,246,962
Nobivac®: Canine Flu H3N8
Canine influenza virus
U.S. Patent No. 7,959,929
U.S. Patent No. 9,345,758
Nobivac®: Lyme
Borrelia Burgdorferi Bacterin
U.S. Patent No. 8,137,678
U.S. Patent No. 8,414,901
Nuflor Gold®
Florfenicol
U.S. Patent No. 8,034,845
Orbax® Oral Suspension
Orbifloxacin
U.S. Patent No. 6,514,492
Posatex® Otic Suspension
Orbifloxacin, Mometasone Furoate monohydrate and Posaconazole, Suspension
U.S. Patent No. 5,661,151
U.S. Patent No. 8,084,445
U.S. Patent No. 8,609,645
Prestige® V+ WNV with Havlogen®
ENCEPHALOMYELITIS-RHINOPNEUMONITIS-INFLUENZA-WEST NILE VIRUS VACCINE, Eastern and Western Killed Virus, Killed Flavivirus Chimera
U.S. Patent No. 8,048,459
U.S. Patent No. 8,133,712
Resflor Gold®
Florfenicol and Flunixin Meglumine
U.S. Patent No. 6,787,568
U.S. Patent No. 6,790,867
U.S. Patent No. 8,044,102
Revolor-XS
Trenbolone acetate and Estradiol
U.S. Patent No. RE39, 592
Vision® 8 Somnus with SPUR®
Clostridium Chauvoei-Septicum-Haemolyticum-Novyi-Sordellii-Perfringens Types C&D-Haemophilus Somnus Bacterin-Toxoid with SPUR
U.S. Patent No. 6,743,430
Zilmax®
Zilpaterol hydrochloride
U.S. Patent No. 8,580,772
Zuprevo®
Tildipirosin
U.S. Patent No. 6,514,946
U.S. Patent No. 8,227,429

Revised Date: 8/16/18



A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | X | Y | Z



BELSOMRA®
(suvorexant)
Tablets
U.S. Patent No. 7,951,797
BRIDION®
(sugammadex sodium injection)
For intravenous use
U.S. Patent No. RE44,733
CLARINEX®
RediTabs
(desloratadine) for oral use
U.S. Patent No. 6,100,274
U.S. Patent No. 7,618,649
CLARINEX-D® 12 HOUR
Extended Release Tablets
(desloratadine/ pseudoephedrine sulfate) for oral use

U.S. Patent No. 6,100,274
U.S. Patent No. 6,709,676
U.S. Patent No. 7,618,649
CLARINEX-D® 24 HOUR
Extended Release Tablets
(desloratadine/ pseudoephedrine sulfate) for oral use
U.S. Patent No. 6,100,274
U.S. Patent No. 7,618,649
DIFICID®
(fidaxomicin)
Tablets for oral use
U.S. Patent No. 8,586,551
U.S. Patent No. 7,863,249
U.S. Patent No. 7,378,508
DULERA®
(mometasone furoate and formoterol fumarate dihydrate)
Inhalation Aerosol
U.S. Patent No. 7,067,502
U.S. Patent No. 7,566,705
EMEND®
(aprepitant)
Capsules 125/80 mg
U.S. Patent No. 8,258,132
EMEND®
(aprepitant)
Capsules 40mg
U.S. Patent No. 8,258,132
EMEND®
(aprepitant)
for oral suspension (125 mg)
U.S. Patent No. 8,258,132
EMEND® IV
(fosaprepitant dimeglumine)
for Injection, for intravenous use
U.S. Patent No. 5,691,336
Follistim AQ® Cartridge
(follitropin beta injection)
for subcutaneous use
U.S. Patent No. 7,446,090
U.S. Patent No. 7,563,763
INTRON® A
Interferon alfa-2b, recombinant For Injection
Powder for Injection
U.S. Patent No. 6,610,830
INTRON® A
Interferon alfa-2b, recombinant For Injection
Solution Vials for Injection
U.S. Patent No. 6,610,830
INTRON® A
Interferon alfa-2b, recombinant For Injection
Solution in Multidose Pens for Injection
U.S. Patent No. 6,610,830
ISENTRESS®
(raltegravir)
Film-coated Tablets for oral use
U.S. Patent No. 7,169,780
U.S. Patent No. 7,754,731
ISENTRESS®
(raltegravir)
Chewable Tablets for oral use
U.S. Patent No. 7,169,780
U.S. Patent No. 7,754,731
JANUMET®
(sitagliptin/metformin HCl)
Tablets
U.S. Patent No. 6,699,871
U.S. Patent No. 7,326,708
U.S. Patent No. 7,125,873
JANUMET® XR
(sitagliptin and metformin HCl extended-release)
Tablets
U.S. Patent No. 6,699,871
U.S. Patent No. 7,326,708
U.S. Patent No. 7,125,873
JANUVIA®
(sitagliptin)
Tablets
U.S. Patent No. 6,699,871
U.S. Patent No. 7,326,708
JUVISYNC
(sitagliptin and simvastatin)
Tablets
U.S. Patent No. 6,699,871
U.S. Patent No. 7,326,708
U.S. Patent No. 7,125,873
U.S. Patent No. 8,168,637
KEYTRUDA®
(pembrolizumab)
For Injection
50 mg
U.S. Patent No. 8,354,509
U.S. Patent No. 8,900,587
NEXPLANON®
(etonogestrel)
Implant
U.S. Patent No. 8,722,037
NOXAFIL®
(Posaconazole)
Oral Suspension 40 mg/mL Injection 18 mg/mL Delayed-Release Tablet 100 mg
U.S. Patent No. 5,661,151
PegIntron®
(Peginterferon alfa-2b) Injection, Powder for Solution for Subcutaneous Use
Single-Use Vial (with 1.25 mL diluent)
U.S. Patent No. 6,180,096
U.S. Patent No. 6,610,830
PegIntron®
(Peginterferon alfa-2b) Injection, Powder for Solution for Subcutaneous Use
REDIPEN®
U.S. Patent No. 6,180,096
U.S. Patent No. 6,610,830
PREVYMIS™
(letermovir)
U.S. Patent No. RE46,791
U.S. Patent No. 8,513,255
SEGLUROMET™
(ertugliflozin and metformin)
Tablets for oral use
U.S. Patent No. 8,080,580
SIVEXTRO®
(tedizolid phosphate)
Powder for Infusion and Oral tablets
U.S. Patent No. 7,816,379
U.S. Patent No. 8,420,676
STEGLATRO™
(ertugliflozin)
Tablets for oral use
U.S. Patent No. 8,080,580
STEGLUJAN™
(ertugliflozin and sitagliptin)
Tablets for oral use
U.S. Patent No. 8,080,580
SYLATRON™
(peginterferon alfa-2b) for injection, for subcutaneous use
Lyophilized powder in single-use vial
U.S. Patent No. 6,180,096
U.S. Patent No. 6,610,830
TEMODAR®
(temozolomide)
for Injection
U.S. Patent No. 6,987,108
U.S. Patent No. 7,786,118
U.S. Patent No. 8,623,868
ZEPATIER®
(elbasvir/grazoprevir)
Tablets for oral use
U.S. Patent No. 8,871,759
U.S. Patent No. 7,973,040
ZERBAXA®
(ceftolozane sulfate/tazobactam sodium)
Powder for infusion
U.S. Patent No. 7,129,232
ZINPLAVA™
(bezlotoxumab)
Injection, for intravenous use
U.S. Patent No. 8,257,709
ZOLINZA®
(vorinostat)
Capsules
U.S. Patent No. 7,456,219
U.S. Patent No. 7,652,069
U.S. Patent No. 7,851,509
U.S. Patent No. 8,093,295

Revised Date: 8/16/18



A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | X | Y | Z



COMVAX
[HAEMOPHILUS b CONJUGATE (MENINGOCOCCAL PROTEIN CONJUGATE) and HEPATITIS B (RECOMBINANT) VACCINE]
U.S. Patent No. 6,544,757
RECOMBIVAX HB®
HEPATITIS B VACCINE (RECOMBINANT)
Capsules
U.S. Patent No. 6,544,757

Revised Date: 8/16/18